BofA’s Hartnett says concentrated U.S. stock returns are likely to persist
Lifevantage Corp (NASDAQ:LFVN), a $173 million market cap company with impressive gross profit margins of 80%, saw its Chief Financial Officer Carl Aure sell 2,746 shares of common stock on July 1, 2025, at a price of $13.39, totaling $36,768. Following the transaction, Aure directly owns 133,303 shares of the company. According to InvestingPro analysis, the company currently trades below its Fair Value, while maintaining a "GREAT" financial health score.
On the same day, Aure also exercised options to acquire 2,401 shares of common stock at a price of $0, stemming from Performance Restricted Stock Units. For deeper insights into insider transactions and access to 8 additional ProTips about LFVN, including management’s share buyback activities, check out the comprehensive Pro Research Report available on InvestingPro.
In other recent news, LifeVantage Corporation reported its financial results for the third quarter of 2025, revealing a mixed performance. The company achieved an earnings per share (EPS) of $0.26, exceeding the forecasted $0.20, marking a positive earnings surprise. However, revenues fell short of expectations, coming in at $58.4 million against the anticipated $60.99 million. Despite a strong 21.1% year-over-year revenue growth, the company faced challenges in international markets, with a 7.2% decline in the Asia Pacific and Europe regions. Analysts from Lake Street Capital Markets and Water Tower Research noted these developments during the earnings call, highlighting the company’s ongoing supply chain resolutions and strategic international expansions. The company’s adjusted EBITDA rose by 27% to $6.4 million, reflecting improved profitability. LifeVantage has set its fiscal year 2025 revenue guidance between $228 million and $235 million, anticipating continued growth. The company is also focused on expanding its MINDBODY system, which has been a key driver of growth, especially in the Americas.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.